Identifying different polymorphic forms of pharmaceutical compounds is an important part of drug discovery and development. There is a perception that it is difficult to secure patent protection for new polymorphs. However, with careful drafting and consideration of the specific advantages associated with the polymorph of interest, patents directed to polymorphs of commercial significance can be obtained. This webinar will discuss some of the issues faced during the drafting and prosecution of patent applications for polymorphs and how those issues can be addressed.
This is a technical webinar aimed at: